123 related articles for article (PubMed ID: 12937871)
1. Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand.
Johansson M; Hall J; Reith D; Jackson P; Tilyard M
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):483-7. PubMed ID: 12937871
[TBL] [Abstract][Full Text] [Related]
2. Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand.
Black PN; Lawrence BJ; Goh KH; Barry MS
Eur J Clin Pharmacol; 2000 Aug; 56(5):431-5. PubMed ID: 11009054
[TBL] [Abstract][Full Text] [Related]
3. Differential prescribing of inhaled corticosteroids in New Zealand general practice.
Hall J; Penrose A; Tomlin A; Reid J
N Z Med J; 2003 Aug; 116(1180):U563. PubMed ID: 14581985
[TBL] [Abstract][Full Text] [Related]
4. Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records.
Pethica BD; Penrose A; MacKenzie D; Hall J; Beasley R; Tilyard M
BMJ; 1998 Oct; 317(7164):986-90. PubMed ID: 9765169
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma.
Fitzgerald D; Van Asperen P; Mellis C; Honner M; Smith L; Ambler G
Thorax; 1998 Aug; 53(8):656-61. PubMed ID: 9828851
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA; Yernault JC; Demedts MG; Geusens P
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[TBL] [Abstract][Full Text] [Related]
8. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids.
Mendes ES; Pereira A; Danta I; Duncan RC; Wanner A
Eur Respir J; 2003 Jun; 21(6):989-93. PubMed ID: 12797493
[TBL] [Abstract][Full Text] [Related]
9. [Inhaled corticosteroids: first-line therapy in asthma].
Hajiro T; Ishihara K
Nihon Rinsho; 2001 Oct; 59(10):1967-72. PubMed ID: 11676140
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
Nicolini G; Cremonesi G; Melani AS
Pulm Pharmacol Ther; 2010 Jun; 23(3):145-55. PubMed ID: 19961948
[TBL] [Abstract][Full Text] [Related]
11. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
Ohbayashi H; Yamase H
Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
[TBL] [Abstract][Full Text] [Related]
12. Analysis of inhaled corticosteroid selection in patients with bronchial asthma using a questionnaire survey--effects of age, gender, and disease severity.
Ota K; Hasegawa T; Koya T; Sakagami T; Sekikawa T; Toyabe S; Akazawa K; Arakawa M; Gejyo F; Suzuki E
Allergol Int; 2009 Sep; 58(3):365-71. PubMed ID: 19454838
[TBL] [Abstract][Full Text] [Related]
13. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
14. Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.
Rutherford C; Mills R; Gibson PG; Price MJ
Respirology; 2003 Sep; 8(3):371-5. PubMed ID: 12911833
[TBL] [Abstract][Full Text] [Related]
15. Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland.
Boyter AC; Steinke DT
Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):203-9. PubMed ID: 15624197
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A; Hall I; Spelman R
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.
Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA
J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
van der Molen T; Postma DS; Martin RJ; Herings RM; Overbeek JA; Thomas V; Miglio C; Dekhuijzen R; Roche N; Guilbert T; Israel E; van Aalderen W; Hillyer EV; van Rysewyk S; Price DB
BMC Pulm Med; 2016 May; 16(1):80. PubMed ID: 27184175
[TBL] [Abstract][Full Text] [Related]
19. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
20. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
